SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development ATOS Q1 2026 Earnings EPS Surprise of 8223 Highlights Cost Management in ClinicalStage Biotech Amer Sports Q1 2026 Earnings EPS Beats Estimates by 211 Revenue Not Disclosed RxSight Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Data Unavailable DXC Q1 2026 Earnings EPS Beats Estimates by 833 While Revenue Uncertainty Pressures Shares WTI Q1 2026 Earnings Deep EPS Miss Raises Concerns